Navigation Links
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
Date:5/7/2008

involve a number of risks and uncertainties, such as risks associated with preclinical and clinical development of Regeneron's drug candidates, determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron's ability to continue to develop or commercialize its product and drug candidates, competing drugs that are superior to Regeneron's product and drug candidates, uncertainty of market acceptance of Regeneron's product and drug candidates, unanticipated expenses, the availability and cost of capital, the costs of developing, producing, and selling products, the potential for any collaboration agreement, including Regeneron's agreements with the sanofi-aventis Group and Bayer HealthCare, to be cancelled or to terminate without any product success, risks associated with third party intellectual property, and other material risks. A more complete description of these and other material risks can be found in Regeneron's filings with the United States Securities and Exchange Commission (SEC), including its Form 10-Q for the quarter ended March 31, 2008. Regeneron does not undertake any obligation to update publicly any forward-looking statement, whether as a result of new information, future events, or otherwise unless required by law.

Contact at Bayer HealthCare:

Astrid Kranz, Phone: +49-30-468-12057,

E-mail: astrid.kranz@bayerhealthcare.com ;

Rose Talarico, Phone: +1-973-305-5258,

E-mail: rose.talarico@bayer.com .

Contact at Regeneron:

Laura Lindsay, Phone: +1-914-345-7800,

E-mail: laura.lindsay@regeneron.com ;

Lauren Tortorete, Phone: +1-212-845-5609,

E-mail: ltortorete@biosector2.com .


'/>"/>
SOURCE Bayer HealthCare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
4. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
5. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Tainted Chinese Food Ingredients First Discovered in 2005
10. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
11. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 2014 Research and Markets has ... - Global Strategic Business Report" report to their ... markets for Pharmaceutical Contract Manufacturing in US$ Thousand by ... solutions), Solid Dosage Forms (Tablets and Capsules), and Liquid ... Ointments). The report provides separate comprehensive analytics ...
(Date:8/19/2014)... Aug. 19, 2014  Tokyo-based Atonarp Inc. announced ... round led by Walden Riverwood Ventures with participation ... of Atonarp,s Smart Spectrometer technology platform, which will ... has targeted the oil & gas and healthcare ... are excited to partner with Atonarp in pursuing ...
(Date:8/19/2014)... Research and Markets has announced the ... by Technology, by Application & by Region- Global Trends & ... The demand for membranes is estimated to increase at ... $29.31 billion Membrane technology was first commercialized in ... filtration and kidney dialysis. In modern times, membranes find extensive ...
Breaking Medicine Technology:Global Pharmaceutical Contract Manufacturing - Strategic Business Report 2014 2Atonarp Inc. Raises $8M Series A Round Led by Walden Riverwood Ventures 2Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2
(Date:8/20/2014)... Kan. (PRWEB) August 20, 2014 B. ... exclusively to healthcare providers, has been retained to lead ... Good Shepherd Health Care System in Hermiston, Ore. The ... industry, B. E. Smith has recently placed more than ... Health Care System is a progressive, not-for-profit healthcare organization ...
(Date:8/20/2014)... 20, 2014 Inc. Magazine recently ... its 33rd annual Inc. 500|5000, an exclusive ranking ... represents the most comprehensive look at the most ... such as Yelp, Pandora, Timberland, Dell, Domino’s Pizza, ... early exposure as members of the Inc. 500|5000. ...
(Date:8/20/2014)... Ticketability.com has Theresa Caputo tickets ... The well-known medium has been thrilling many with her ... 19 cities, with tickets becoming available August 15. , ... are Albany, Baltimore, Trenton, Erie, Buffalo, Philadelphia, Charlotte, Houston, ... San Diego. The medium’s fans can obtain Theresa Caputo ...
(Date:8/20/2014)... 2014 The “Human Insulin Market ... Acting, Premixed), Modern Human Insulin (Rapid Acting, Long ... Novomix, Tresiba, Others) - Forecast to 2019” provides ... opportunities, current market trends,and strategies impacting the global ... forecasts of the revenue and share analysis. , ...
(Date:8/20/2014)... Los Angeles, CA (PRWEB) August 20, 2014 ... will honor the 2014 Emmy Award Nominees and Presenters at ... place on August 22nd and 23rd in Beverly Hills from ... enjoy gifts, refreshments and music by DJ Morgan Hildebrand. , ... charity fundraising and will feature several charities at the lounge. ...
Breaking Medicine News(10 mins):Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 2Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 3Health News:Etransmedia Makes Exclusive List for the Eighth Consecutive Year in Inc. Magazine 2Health News:Etransmedia Makes Exclusive List for the Eighth Consecutive Year in Inc. Magazine 3Health News:Theresa Caputo Tour Tickets for Sale at Ticketability.com Cause a Buying Frenzy Among Customers Over Their Offering of Deeply Discounted Seats 2Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 2Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 3Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 4
... DENVER and GOLDEN, Colo., Feb. 4 ABR-Affinity,BioReagents, ... sciences,research community and exclusive supplier to Thermo Fisher ... Scientific National Sales,Meeting and Supplier Expo, held January ... Convention Center in San Antonio, Texas. With an ...
... magnets pose almost-fatal attractions when swallowed by kids, new report ... the story of a little boy who swallowed a magnet ... 4, of San Jose, Calif., swallowed two tiny magnets from ... spring. , After the first ingestion, he confessed to his ...
... Parkinson,s, Alzheimer,s and ... Certain Forms of Cancer, FOSTER CITY, ... since PLAYSTATION(R)3 (PS3(R)) took part,in Stanford University,s Folding@home(TM) project on March ... million users. This,equates to roughly 3,000 PS3 users registering for Folding@home ...
... Youth Display 642 Pairs of Shoes Symbolizing Deaths Caused ... Members of the,statewide youth advocacy group H.O.T. (Helping ... at the State Capitol Rotunda to,highlight the problem of ... pairs of shoes on the steps of the Capitol, ...
... have a pretty good idea why your husband or boyfriend ... study, the Stanford University School of Medicine researchers have shown ... is more activated in men than women during video-game play. ... more attracted to, and more likely to become ,hooked, on ...
... Forms Alliance With Veterinary News Network, MODESTO, ... in,veterinary hospital captive audience digital signage solutions and ... one of the,most comprehensive client education systems in ... partnering with emebaVet, bringing interesting,and accurate pet health ...
Cached Medicine News:Health News:ABR-Affinity BioReagents Participates in the 2008 Fisher Scientific Supplier Expo in San Antonio, Texas 2Health News:Toy Magnets Can be a Very Real Threat 2Health News:Toy Magnets Can be a Very Real Threat 3Health News:One Million PLAYSTATION(R)3 Users Participate in Folding@home Research Project 2Health News:One Million PLAYSTATION(R)3 Users Participate in Folding@home Research Project 3Health News:Video games activate reward regions of brain in men more than women, Stanford study finds 2Health News:Video games activate reward regions of brain in men more than women, Stanford study finds 3Health News:emebaVet, LLC Client Education System Gets Bigger and Better in 2008 2Health News:emebaVet, LLC Client Education System Gets Bigger and Better in 2008 3
ENDO STITCH™ Single Use Loading Units....
The ENDO CLOSE™ trocar site closure device has application in laparoscopic procedures for approximation of tissues and percutaneous suturing for closing incision sites....
This ENDOLOOP suture has a suture type - 0 PDSII and a 1.5 inch diameter....
... ligature inserted into a plastic tube. The plastic tube ... other. The suture protrudes from the narrow end and ... which becomes secure after the device is activated. The ... scored end of the plastic tube. The scored end ...
Medicine Products: